JPWO2023186873A5 - - Google Patents
Info
- Publication number
- JPWO2023186873A5 JPWO2023186873A5 JP2024557570A JP2024557570A JPWO2023186873A5 JP WO2023186873 A5 JPWO2023186873 A5 JP WO2023186873A5 JP 2024557570 A JP2024557570 A JP 2024557570A JP 2024557570 A JP2024557570 A JP 2024557570A JP WO2023186873 A5 JPWO2023186873 A5 JP WO2023186873A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- region
- antigen
- nucleic acid
- scfv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382294.1A EP4253418A1 (en) | 2022-03-29 | 2022-03-29 | Immune cells expressing chimeric antigen receptors and bispecific antibodies and uses thereof |
| EP22382294.1 | 2022-03-29 | ||
| PCT/EP2023/057957 WO2023186873A1 (en) | 2022-03-29 | 2023-03-28 | Immune cells expressing chimeric antigen receptors and bispecific antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025510336A JP2025510336A (ja) | 2025-04-14 |
| JP2025510336A5 JP2025510336A5 (https=) | 2026-04-07 |
| JPWO2023186873A5 true JPWO2023186873A5 (https=) | 2026-04-07 |
Family
ID=81326113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557570A Pending JP2025510336A (ja) | 2022-03-29 | 2023-03-28 | キメラ抗原受容体及び二重特異性抗体を発現する免疫細胞及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250186588A1 (https=) |
| EP (2) | EP4253418A1 (https=) |
| JP (1) | JP2025510336A (https=) |
| CN (1) | CN119256011A (https=) |
| CA (1) | CA3255076A1 (https=) |
| WO (1) | WO2023186873A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22545A1 (es) | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
| US4943533A (en) | 1984-03-01 | 1990-07-24 | The Regents Of The University Of California | Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor |
| US4694778A (en) | 1984-05-04 | 1987-09-22 | Anicon, Inc. | Chemical vapor deposition wafer boat |
| EP0491007B1 (en) | 1989-09-08 | 1996-03-13 | The Johns Hopkins University | Structural alterations of the egf receptor gene in human gliomas |
| EP0659439B1 (en) | 1993-12-24 | 2001-10-24 | MERCK PATENT GmbH | Immunoconjugates |
| AU6267896A (en) | 1995-06-07 | 1996-12-30 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth oftumors |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| DE10143237A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente) |
| US20050112095A1 (en) | 2002-07-09 | 2005-05-26 | Tsu-An Hsu | Internal ribosome entry sites for recombinant protein expression |
| HRP20110498T1 (hr) | 2005-10-07 | 2011-08-31 | Exelixis | Azetidini kao inhibitori mek za liječenje proliferativnih bolesti |
| ES2342646B1 (es) | 2008-06-02 | 2011-04-26 | Institut De Recerca Hospital Universitari Vall Hebron | Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas. |
| GB0906576D0 (en) | 2009-04-16 | 2009-05-20 | Animal Health Inst | Internal ribosome entry site |
| KR20240005168A (ko) | 2016-11-04 | 2024-01-11 | 2세븐티 바이오, 인코포레이티드 | 항-bcma car t 세포 조성물 |
| EP3915576A1 (en) | 2020-05-28 | 2021-12-01 | Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron | Chimeric antigen receptors specific for p95her2 and uses thereof |
-
2022
- 2022-03-29 EP EP22382294.1A patent/EP4253418A1/en not_active Withdrawn
-
2023
- 2023-03-28 JP JP2024557570A patent/JP2025510336A/ja active Pending
- 2023-03-28 WO PCT/EP2023/057957 patent/WO2023186873A1/en not_active Ceased
- 2023-03-28 CA CA3255076A patent/CA3255076A1/en active Pending
- 2023-03-28 US US18/852,440 patent/US20250186588A1/en active Pending
- 2023-03-28 CN CN202380042186.4A patent/CN119256011A/zh active Pending
- 2023-03-28 EP EP23716429.8A patent/EP4499692A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021087455A5 (https=) | ||
| JP2021094037A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| JP2025065142A5 (https=) | ||
| FI4063397T3 (fi) | Yksidomeenivasta-aineisiin perustuvia antigeenireseptoreita ja menetelmiä niiden käyttämiseksi | |
| JP2019527557A5 (https=) | ||
| JP2021526844A5 (https=) | ||
| JP2025142045A5 (https=) | ||
| CN118852460A (zh) | 具有非FcγR依赖性激动活性的肿瘤坏死因子(TNF)受体超家族(TNFRSF)受体-激活抗体融合蛋白(具有非FcγR依赖性激动活性的TNFRSF受体-激活抗体融合蛋白；TRAAFFIAA) | |
| WO2020102233A1 (en) | Bispecific antibodies for activation of immune cells | |
| JP2019527537A5 (https=) | ||
| JP7503642B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| JP2018533371A5 (https=) | ||
| KR20230143177A (ko) | 신규한 항-cd24 항체 | |
| JP2021516951A5 (https=) | ||
| JP2020512973A5 (https=) | ||
| JPWO2020132190A5 (https=) | ||
| JPWO2019245991A5 (https=) | ||
| JPWO2023186873A5 (https=) | ||
| JPWO2022012681A5 (https=) | ||
| JPWO2022127871A5 (https=) | ||
| JPWO2022159653A5 (https=) | ||
| TWI918721B (zh) | Egfr結合複合物及其製備和使用方法 | |
| JPWO2022218380A5 (https=) | ||
| JPWO2023062604A5 (https=) |